Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas at Austin
The goal of this project is to test the efficacy of LLLT to enhance neurocognitive function in middle-aged adults and examine the modulating influences of carotid atherosclerosis. The specific aims will be accomplished in a randomized controlled trial (RCT) by examining cognitive test performance and blood oxygen level-dependent (BOLD) response to a working memory task in middle-aged and older adults and participants with Mild Cognitive Impairment pre- and post- six-week long intervention of LLLT or placebo. In addition, the investigators will examine if carotid artery intima-media thickness (IMT) moderates the therapeutic effects of LLLT.
Age
45–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Men and postmenopausal women, aged 45 and older
Participants with Mild Cognitive Impairment
You may not be if
neurological disease (e.g., large vessel stroke, seizure disorder, Parkinson's disease, Alzheimer's disease, clinically significant traumatic brain injury with loss of consciousness \> 30 minutes, multiple sclerosis, or brain infection/meningitis
baseline IQ \< 85 placing them below the average range of intellectual functioning
major psychiatric illness (e.g., schizophrenia, bipolar disorder) or substance abuse (diagnosed abuse and/or previous hospitalization for substance abuse)
severe cardiovascular disease (e.g., pacemaker), chronic obstructive pulmonary disease, liver or kidney disease, inflammatory illness
Clareo Health | Cognitive Enhancement Through Transcranial Laser Therapy
